Kowsar Biotechnology

Kowsar Biotechnology Center is a prominent Iranian biotechnology company specializing in molecular genetics, diagnostics, and genomic services. Founded by Dr. Sirous Zeinali, the center provides a comprehensive suite of services including Sanger sequencing, Next-Generation Sequencing (NGS), and custom oligonucleotide synthesis. The company develops and manufactures a variety of molecular diagnostic kits targeting genetic disorders such as Thalassemia and Cystic Fibrosis, as well as infectious diseases like COVID-19 and HPV. Kowsar serves as a critical infrastructure provider for clinical genetics in the Middle East, offering bioinformatics analysis and specialized laboratory testing to healthcare providers. Their facilities are equipped for high-throughput genetic analysis, supporting both clinical diagnostics and academic research.